TheJobsMapTOLREMO therapeutics jobs and careers
Zürich, Switzerland
As of October 24, 2026, TOLREMO therapeutics has no open roles listed.
About TOLREMO therapeutics
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.
Founded in 2017 by Emmanuel Savioz, Isaac Kobrin, Karl-Heinz Altmann, Stefanie Flückiger-Mangual and Wilhelm Krek.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $19.5M
- Headquarters
- Zürich
Leadership
The top of TOLREMO therapeutics's org chart, with how many people report into each leader.
SF
Stefanie Flückiger-Mangual
CEO
5 reports
FV
Florian Vogl
Chief Medical Officer
1 report
CE
Claudia Escher
Chief Operating Officer
1 report
JC
Jessica Corson
Chief Business Officer
Board
EG
Erich Greiner
Board Member
MW
Michael Wacker
Board Member
JC
Julie M Cherrington
Chair
Jobs at TOLREMO therapeutics
No open positions right now. Explore more companies on TheJobsMap.
TOLREMO therapeutics jobs: common questions
- Is TOLREMO therapeutics hiring right now?
- TOLREMO therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on TOLREMO therapeutics's careers site.
- Where is TOLREMO therapeutics headquartered?
- TOLREMO therapeutics is headquartered in Zürich, Switzerland and was founded in 2017.
- Who leads TOLREMO therapeutics?
- Stefanie Flückiger-Mangual, CEO, is at the top of TOLREMO therapeutics's org chart.
- How do I apply for a job at TOLREMO therapeutics?
- Pick a role on TOLREMO therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on TOLREMO therapeutics's own careers site, so you apply directly with the employer.